HOME >> BIOLOGY >> NEWS
Researchers identify genetic mutation that may alter tumor cell proliferation

Indianapolis, July 4, 2007 -- Researchers from Eli Lilly & Company and the Phoenix-based Translational Genomics Research Institute (TGen) today announced finding a novel recurring mutation of the gene AKT1 in breast, colorectal and ovarian cancers. The altered form of AKT1 appears to cause tumor cell proliferation and may play a role in making cells resistant to certain types of therapies. The findings are reported in an advance online publication (AOP) of the journal Nature.

The PI3-Kinase/AKT pathway is among the most commonly activated cellular pathways in human cancers and members of this pathway are among the most frequently targeted for new cancer drug discovery efforts. Activation of this pathway results in cancer cell growth and cell survival. Although AKT1 is central to pathway activation, its role in cancer has been that of an intermediary between mutated upstream regulatory proteins and downstream survival signaling proteins. This is the first evidence of direct mutation of AKT1 in human cancer tumors: it was discovered in clinical samples from cancer patients, yet has never been detected in cancer cell lines.

This discovery is a seminal finding in cancer biology that confirms AKT1 as an oncogene in breast, colorectal and ovarian cancer. The mutation alters the electrostatics of binding pocket in the pleckstrin homology domain, the portion of the enzyme that docks with phospholipids on the cell membrane, said Kerry L. Blanchard, PhD, MD, Executive Director, Discovery Biology Research, Eli Lilly & Company.

To identify the AKT1 mutation, the researchers analyzed 150 tumor samples from patients with either breast, colorectal or ovarian cancer (50 samples from each tumor type). Analysis of the data showed that 8 percent of breast, 6 percent of colorectal and 2 percent of ovarian tumors had the AKT1 mutation in the samples that were screened in their study.

Recently, molecular features such as the AKT1 mutation are
'"/>

Contact: Amy Erickson
aerickson@tgen.org
602-343-8522
The Translational Genomics Research Institute
4-Jul-2007


Page: 1 2 3

Related biology news :

1. Researchers find pathway that controls cell size and division
2. Researchers watch antibiotics, bacteria meet at atomic level
3. Researchers discover gene responsible for Restless Legs Syndrome
4. Researchers witness natural selection at work in dramatic comeback of male butterflies
5. Researchers discover human embryonic stem cells are the ultimate perpetual fuel cell
6. Researchers use new approach to predict protein function
7. Researchers probe risks, benefits of folic acid fortification
8. Researchers discover method for identifying how cancer evades the immune system
9. Researchers use adult stem cells to create soft tissue
10. Researchers find gene that spurs development of the epididymis
11. Researchers isolate new risk marker for overweight children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/14/2019)... ... ... Highmark Health’s VITAL Innovation Platform has been named the winner in the ... of the top honors in the awards. Winners were announced at an event on ... event on May 10 that also raises funds for Carnegie Science Center programs that ...
(Date:3/11/2019)... ORLANDO, Fla. (PRWEB) , ... March 11, 2019 , ... ... parenting among U.S. LGBTQ Millennials compared to previous generations; 77% of those aged 18 ... 54 age group and 33% of those aged 55 and older.(1) Among all LGBTQ ...
(Date:3/9/2019)... ... March 07, 2019 , ... StressMarq Biosciences Inc., a ... today announced the publication of its recent PCT patent application describing ... a pre-clinical stage of development, moves the company into the drug discovery field. ...
Breaking Biology News(10 mins):
(Date:3/15/2019)... (PRWEB) , ... March 15, ... ... of 100% equity in American Process Inc. and affiliate companies including AVAPCO ... Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center in Thomaston, ...
(Date:3/14/2019)... ... March 14, 2019 , ... Open registration ... “Navigating the Full Spectrum of Case Management,” continues as CMSA makes plans to ... is the only case management industry conference serving the educational and networking needs ...
(Date:3/14/2019)... ... March 13, 2019 , ... ... 2019 ISPE Europe Biotechnology Conference , taking place in Brussels, Belgium on 25–26 ... practices, technical and operational solutions, and innovative approaches. , “Biopharmaceuticals have become ...
(Date:3/12/2019)... ... March 12, 2019 , ... Diagenode, ... has launched its third generation long-fragment DNA shearing innovation, the Megaruptor 3. This ... user-friendly interface, automated processing, and the ability to process up to 8 ...
Breaking Biology Technology:
Cached News: